Facebook Tracking Image

National Comprehensive Cancer Network



Educational Events & Programs

Oncology Policy Summit Banner

Live webinar was held September 9, 2020.

 

OVERVIEW

The Summit will explore diverse perspectives related to emerging models to drive down healthcare costs in the United States and their potential impact on access to high-quality cancer care. Major themes of the summit will include an overview of legislative and regulatory efforts to reduce health costs, the current state of value-based payment models, and the impact of these models on providers and patients with cancer. The summit will also explore the unique implications of policies intended to curb costs for rural and other underserved populations.

Please check back often for additional agenda updates regarding this summit. If you have any questions, please contact Terrell Johnson, Manager, Policy and Advocacy, johnson@nccn.org.


AGENDA*

10:00 – 10:05 AM

Welcome and Introductions
Alyssa Schatz, MSW, National Comprehensive Cancer Network

10:10 – 10:55 AM

Keynote – Innovative Reimbursement Models in Medicare and Medicaid

Lara Strawbridge, MPH
Center for Medicare and Medicaid Innovation (CMMI)

11:00 – 11:40 AM

Fireside Chat – Legislative Proposals to Reduce Cost and Considerations for Protecting Access to High Quality Cancer Care
Moderated by Clifford Goodman, PhD, The Lewin Group

Afton Cissell, JD
Office of Congressman Lloyd Doggett

Brett Baker
Office of Senator Chuck Grassley

11:45 – 11:55 AM

Break

11:55 AM – 12:55 PM

Panel Discussion – Perspectives on the Future of Lowering Costs in the American Healthcare System and Implications for the Oncology Community
Moderated by Clifford Goodman, PhD, The Lewin Group

Angela Mysliwiec, MD
WellMed

Ted Okon, MBA
Community Oncology Alliance

Ruth O’Regan, MD
University of Wisconsin Carbone Cancer Center

Gena Cook
Navigating Cancer

1:00 – 1:40 PM

Fireside Chat – Getting Providers and Payers to the Other Side: Best Practices for Succeeding in Commercial Value-Based Agreements

Moderated by Clifford Goodman, PhD, The Lewin Group

Thomas Daly
University of Michigan Health System

David Rubin
Memorial Sloan Kettering Cancer Center

1:40 – 2:15 PM

Keynote – Lowering the Overall Cost of Care and Concerns for Equity

Michelle McMurry-Heath, MD, PhD
Bio

2:20 – 2:30 PM Wrap-up and Conclusions
Terrell Johnson, MPA, National Comprehensive Cancer Network

*Topics subject to change.


SUPPORTERS

Supported by Adaptive; ADC Therapeutics; AmerisourceBergen; Amgen; Apobiologix; Astellas; AstraZeneca through its NCCN Corporate Council Membership; BeiGene, Ltd.; bluebird bio; Dendreon Pharmaceuticals; Eisai Inc; EMD Serono; Exelixis; Foundation Medicine, Inc.; Genentech; GSK; Heron; Incyte Corporation; Janssen Oncology; Kite, a Gilead Company; an independent educational grant from Merck & Co., Inc.; MorphoSys US, Inc.; Novartis; Regeneron Pharmaceuticals, Inc.; Sun Pharma Oncology; Takeda; and Verastem Oncology. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Lilly Oncology; and this activity was made possible by Pharmacyclics, an AbbVie Company.

As of August 27, 2020.


Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.